// App-Quantinova.ai

: The burden of intermittent oral corticosteroid use in asthma

Researchers

Presenter

  • Heath Heatley

Principal Investigators

  • Trung Tran

  • Arnaud Bourdin

  • Andrew Menzies-Gow

  • David Jackson

  • Ekaterina Maslova

  • Derek Skinner

  • Victoria Carter

  • David Price

Medical Centers

  • UK Severe Asthma Network and National Registry, Guy's and St Thomas' NHS Trust and Division of Asthma, Allergy & Lung Biology, King's College London, London, United Kingdom,

  • Astra Zeneca, Cambridge, United Kingdom

  • Observational and Pragmatic Research Institute, Singapore, Singapore,

  • Montpellier University Hospitals, Arnaud de Villeneuve Hospital, Montpellier, France

  • UK Severe Asthma Network and National Registry, Royal Brompton & Hareï¬eld NHS Foundation Trust, London, United Kingdom,

  • AstraZeneca Gaithersburg, Gaithersburg, United States of America

Locations

  • United States

  • Singapore

  • United Kingdom

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved